Second Primary Lung Cancer Among Lung Cancer Survivors Who Never Smoked.

ABSTRACT:

Importance

Lung cancer among never-smokers accounts for 25% of all lung cancers in the US; recent therapeutic advances have improved survival among patients with initial primary lung cancer (IPLC), who are now at high risk of developing second primary lung cancer (SPLC). As smoking rates continue to decline in the US, it is critical to examine more closely the epidemiology of lung cancer among patients who never smoked, including their risk for SPLC.

Objective

To estimate and compare the cumulative SPLC incidence among lung cancer survivors who have never smoked vs those who have ever smoked.

Design, setting, and participants

This population-based prospective cohort study used data from the Multiethnic Cohort Study (MEC), which enrolled participants between April 18,

SUBMITTER: Choi E 

PROVIDER: S-EPMC10652150 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature